Quarterly Report • Aug 28, 2020
Quarterly Report
Open in ViewerOpens in native device viewer
S I X M O N T H S E N D E D 30 JUNE 2020
In accordance with International Financial Reporting Standards
Management and the Board of Directors have today considered and approved the interim consolidated financial statements of Atlantic Sapphire ASA (collectively, the "Group") for the period 1 January 2020 to 30 June 2020. The interim report, which has not been audited or reviewed by the Group's independent auditors, has been prepared in accordance with IAS 34 Interim Financial Reporting as adopted by the EU disclosure requirements for listed companies. In our opinion, the accounting policies used are appropriate, and the interim report gives a true and fair view of the Group's financial position at 30 June 2020, as well as the
results of the Group's activities and cash flows for the period 1 January 2020 to 30 June 2020. In our opinion, Management's review provides a true and fair presentation of developments, results for the period, and overall financial position of the Group's operations in addition to a description of the most significant risks and elements of uncertainty facing the Group. Over and above the disclosures in the interim report, no changes in the Group's most significant risks and uncertainties have occurred relative to the disclosures in the annual report for 2019.
Vikebukt, 27 August 2020
Johan E. Andreassen Chairman
André Skarbø Director
Tone Bjørnov Director
Ellen Marie Sætre Director
Runar Vatne Director
Alexander Reus Director
Patrice Flanagan Director
| Unaudited (USD 1,000) | Note | 30 June 2020 | 30 June 2019 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | 2,502 | 2,021 | 5,540 | |
| Expenses | ||||
| Cost of materials | 5,328 | 2,187 | 6,582 | |
| Fair value adjustment on biological assets | 3 | 11,216 | (704) | (458) |
| Salary and personnel costs | 2,831 | 1,643 | 3,795 | |
| Other operating expenses | 5,132 | 3,423 | 6,803 | |
| Depreciation and amortization | 4 | 1,289 | 1,039 | 2,286 |
| Total expenses | 25,796 | 7,588 | 19,008 | |
| Operating loss | (23,294) | (5,567) | (13,468) | |
| Financial income | 104 | 183 | 3,640 | |
| Financial expense | (8,467) | (4,062) | (3,338) | |
| Other income, net | 83 | 3 | 14 | |
| Loss before income tax benefit | (31,574) | (9,443) | (13,152) | |
| Income tax benefit | - | - | - | |
| Net loss | (31,574) | (9,443) | (13,152) | |
| Earnings per share: Basic earnings per share Diluted earnings per share |
(0.46) (0.46) |
(0.15) (0.15) |
(0.19) (0.19) |
| Unaudited (USD 1,000) | Note | 30 June 2020 | 30 June 2019 | 31 Dec 2019 |
|---|---|---|---|---|
| Net loss | (31,574) | (9,443) | (13,152) | |
| Exchange difference on translation of foreign operations | 126 | 7,884 | (917) | |
| Total comprehensive loss | (31,448) | (1,559) | (14,069) |
| Unaudited (USD 1,000) | Note | 30 June 2020 | 30 June 2019 | 31 Dec 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| Non-current assets Property, plant, and equipment, net |
||||
| Right of use asset | 4 | 241,147 | 170,185 | 209,616 |
| Restricted cash (long-term) | 446 | - | 355 | |
| Security deposits | - | 15,000 | 15,000 | |
| Patents | 821 | 264 | 726 | |
| Other investments | - 11 |
174 11 |
- 11 |
|
| Trade and other receivables (long-term) | 81 | 275 | 118 | |
| Total non-current assets | 242,506 | 185,909 | 225,826 | |
| Current assets | ||||
| Prepaid and other current assets | 649 | 1,215 | 1,933 | |
| Inventories | 3,337 | 155 | 3,302 | |
| Biological assets | 3 | 8,070 | 7,386 | 11,275 |
| Trade and other receivables (short-term) | 612 | 1,419 | 1,069 | |
| Restricted cash (short-term) | 332 | 309 | 324 | |
| Cash | 10,815 | 65,706 | 9,147 | |
| Total current assets | 23,815 | 76,190 | 27,050 | |
| TOTAL ASSETS | 266,321 | 262,099 | 252,876 | |
| EQUITY AND LIABILITIES Equity |
||||
| Share capital | ||||
| Share premium | 6 6 |
818 236,851 |
818 236,819 |
818 236,819 |
| Employee stock options | 6 | 1,503 | 983 | 1,060 |
| Accumulated deficit | (59,006) | (27,782) | (27,432) | |
| Accumulated other comprehensive (loss) gain | (2,460) | 5,298 | (2,586) | |
| Total equity | 177,706 | 216,136 | 208,679 | |
| Non-current liabilities | ||||
| Borrowings (long-term) | 5 | 71,116 | 27,135 | 27,319 |
| Lease liability (long-term) | 487 | - | 379 | |
| Total non-current liabilities | 71,603 | 27,135 | 27,698 | |
| Current liabilities | ||||
| Borrowings (short-term) | 5 | - | 67 | 79 |
| Trade and other payables | 17,012 | 18,761 | 16,420 | |
| Total current liabilities | 17,012 | 18,828 | 16,499 | |
| Total liabilities | 88,615 | 45,963 | 44,197 | |
| TOTAL EQUITY AND LIABILITIES | 266,321 | 262,099 | 252,876 | |
| Unaudited (USD 1,000) | Share capital |
Share premium |
Employee stock options |
Accumulated deficit |
Accumulated other comprehensive loss |
Total equity |
|---|---|---|---|---|---|---|
| Balance at 31 December 2018 | 720 | 151,764 | 904 | (14,280) | (1,669) | 137,439 |
| Contributions Net loss Foreign currency translation adjustments |
98 - - |
85,055 - - |
156 - - |
- (13,152) - |
- - (917) |
85,309 (13,152) (917) |
| Balance at 31 December 2019 | 818 | 236,819 | 1,060 | (27,432) | (2,586) | 208,679 |
| Contributions Net loss Foreign currency translation adjustments |
- - - |
32 - - |
443 - - |
- (31,574) - |
- - 126 |
475 (31,574) 126 |
| Balance at 30 June 2020 | 818 | 236,851 | 1,503 | (59,006) | (2,460) | 177,706 |
| Unaudited (USD 1,000) | Note | 30 June 2020 | 30 June 2019 | 31 Dec 2019 |
|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||
| Net loss | (31,574) | (9,443) | (13,152) | |
| Adjustments to reconcile net loss to net cash | ||||
| used in operating activities | ||||
| Depreciation and amortization | 4 | 1,289 | 1,039 | 2,286 |
| Fair value adjustment on biological assets | 3 | 11,216 | (704) | (458) |
| Loss from disposition of other assets | 31 | - | 25 | |
| Net interest received and paid | 8,349 | 1,730 | 526 | |
| Non-cash employee stock options | 6 | 443 | 411 | 156 |
| Net foreign currency exchange rate differences | 359 | (165) | (153) | |
| Changes in operating assets and liabilities | ||||
| Trade and other receivables | 497 | (894) | (90) | |
| Inventories and biological assets, at cost | 3 | (8,026) | (3,467) | (10,793) |
| Prepaid and other current assets | 1,288 | 1,025 | 41 | |
| Security deposits | (95) | (264) | (726) | |
| Trade and other payables | (2,439) | (467) | 3,776 | |
| Interest received | 14 | - | 100 | |
| Net cash used in operating activities | (18,648) | (11,199) | (18,462) | |
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||
| Payments towards property, plant, and equipment | 4 | (29,676) | (39,032) | (86,790) |
| Right of use asset | (90) | - | - | |
| Net cash used in investing activities | (29,766) | (39,032) | (86,790) | |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||
| Proceeds from borrowings | 5 | 95,156 | 39,544 | 42,595 |
| Payments towards borrowings | 5 | (51,438) | (13,621) | (16,288) |
| Restricted cash on borrowings | 14,991 | (15,309) | (15,005) | |
| Lease liability | 107 | - | - | |
| Proceeds from issuance of capital | 32 | 87,683 | 85,153 | |
| Interest paid | (8,363) | (1,543) | (626) | |
| Net cash provided by financing activities | 50,485 | 96,754 | 95,829 | |
| Net increase (decrease) in cash | 2,071 | 46,523 | (9,423) | |
| Cash at beginning of period | 9,147 | 19,018 | 18,699 | |
| Effects of exchange rate on cash | (403) | 165 | (129) | |
| Cash at end of period | 10,815 | 65,706 | 9,147 | |
Atlantic Sapphire ASA ("ASA") is a Norwegian company headquartered at Vikebukt, Norway and listed on the Oslo Stock Exchange with the ticker symbol "ASA". ASA owns the following subsidiaries (collectively, the "Group"):
The Group's interim consolidated statements for the six months ended 30 June 2020 were prepared in accordance with IAS 34 Interim Financial Reporting under International Financial Reporting Standards ("IFRS") as adopted by the European Union ("EU").
This interim financial report does not include all the notes of the type normally included in an annual financial report. Accordingly, this interim financial report is to be read in conjunction with the Group's Annual Report for the year ended 31 December 2019 and any public announcements made by Atlantic Sapphire ASA during the interim reporting period. The interim report is unaudited and is presented in United States dollars ("USD").
The Group's accounting policies adopted are consistent with those applied in the Group's 2019 Annual Report as published on the Oslo Stock Exchange on 26 March 2020. No new standards under IFRS have been adopted by the Group in 2020.
Certain amounts in the Group's 2019 consolidated financial statements have been reclassified to conform to the 2020 presentation. The reclassifications have no effect on the Group's consolidated financial position or previously reported results of consolidated operations.
The Group has two strategic divisions, which represent its reportable segments. The Group's executive management reviews the internal management reports of each division. As of 30 June 2020, the Group's reportable segments consisted of the following:
The Group owns and operates a proprietary Bluehouse land-based salmon farm in Hvide Sande, Denmark through ASDK. Principal operations consist of the production and sale of salmon.
The Group owns and operates a proprietary Bluehouse land-based salmon farm in Homestead, Florida, USA through ASUS (the "Miami Bluehouse"). The Miami Bluehouse is currently under Phase 1 of its construction build out and is projected to reach approximately 10,000 tons annualized HOG1 production in 2021.
The Group's segment information consisted of the following:
| Six months ended 30 June 2020 | Fish farming | |||
|---|---|---|---|---|
| Unaudited (USD 1,000) | Denmark | USA | Other and eliminations |
Consolidated |
| Revenue from sale of salmon | 2,812 | 172 | (482) | 2,502 |
| EBITDA | (6,243) | (14,136) | (1,543) | (21,922) |
| Pre-tax loss | (8,245) | (22,559) | (770) | (31,574) |
| Total assets | 41,256 | 227,991 | (2,926) | 266,321 |
| Total liabilities | 37,551 | 85,350 | (34,286) | 88,615 |
| Depreciation and amortization | 1,215 | 74 | - | 1,289 |
| Capital expenditures | 1,474 | 31,284 | - | 32,758 |
| Unaudited (USD 1,000) | Denmark | USA | Other and eliminations |
Consolidated |
|---|---|---|---|---|
| Revenue from sale of salmon | 2,021 | - | - | 2,021 |
| EBITDA | (886) | (2,793) | (846) | (4,525) |
| Pre-tax loss | (2,538) | (4,501) | (2,404) | (9,443) |
| Total assets | 42,651 | 172,062 | 47,386 | 262,099 |
| Total liabilities | 35,037 | 43,928 | (33,002) | 45,963 |
| Depreciation and amortization | 342 | 27 | 670 | 1,039 |
| Capital expenditures | 9,334 | 32,771 | 2,994 | 45,099 |
1 HOG – "Head-On-Gutted" fish, a term used industry-wide, is approximately 83% of live weight fish.
ATLANTIC SAPPHIRE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
| Year ended 31 December 2019 | Fish farming | ||||
|---|---|---|---|---|---|
| Unaudited (USD 1,000) | Denmark | USA | Other and eliminations |
Consolidated | |
| Revenue from sale of salmon | 6,413 | - | (873) | 5,540 | |
| EBITDA | (3,147) | (7,124) | (897) | (11,168) | |
| Pre-tax loss | (6,957) | (7,730) | 1,535 | (13,152) | |
| Total assets | 47,319 | 204,387 | 1,170 | 252,876 | |
| Total liabilities | 35,235 | 41,187 | (32,225) | 44,197 | |
| Depreciation and amortization | 2,206 | 80 | - | 2,286 | |
| Capital expenditures | 7,001 | 79,156 | - | 86,157 | |
Significantly all the Group's revenue consisted of the sale of salmon, and the Group's disaggregation of revenue with customers consisted of the following:
| Unaudited (USD 1,000) | 30 June 2020 | 30 June 2019 | 31 Dec 2019 |
|---|---|---|---|
| Revenue from external customers in: | |||
| Denmark | 815 | 397 | 2,390 |
| United States | 639 | 151 | 1,834 |
| Europe | 1,048 | 1,473 | 1,316 |
| Total revenue from external customers | 2,502 | 2,021 | 5,540 |
| Unaudited (USD 1,000) | 30 June 2020 | 30 June 2019 | 31 Dec 2019 |
|---|---|---|---|
| Sales per customer: | |||
| Customer A | 639 | 1,196 | 1,834 |
| Customer B | 619 | 353 | 1,433 |
| Customer C | 196 | 151 | 957 |
| Customer D | 382 | 159 | 607 |
| Customer E | 544 | - | 348 |
| Other customers | 122 | 162 | 361 |
| Total revenue from significant customers | 2,502 | 2,021 | 5,540 |
Under the provisions of IAS 41, the fair value of the Group's biological assets is calculated based on the market price for the relevant fish quality and size on the reporting period date. As the biomass input is mostly unobservable, biomass valuation is categorized at Level 3 in the fair value hierarchy under IFRS 13. The estimated market price in each market is normally derived from the development in recent market prices. Quoted forward prices from Fish Pool, a third-party, are used in the estimation to improve reliability and comparability of the price estimation.
The valuation model for the Group's biological assets calculates the net present value of the expected cash flow from harvested biomass based on the actual number of fish as a starting point. The time to market for live fish is based on a growth table for each generation of fish. The Group considers a live fish weight of 4.5 kg to be the target harvest weight with an expected growth period of 21 months. Expected mortality rates are used to estimate the expected volume of biomass that will reach optimal harvest weight. Fish Pool forward prices are used to determine the expected cash inflows at the time of harvest. Future cash flows are discounted at a monthly rate of 10%. Observable market prices are used where available.
The Group's biological assets consisted of the following:
| Unaudited (USD 1,000) | 30 June 2020 | 30 June 2019 | 31 Dec 2019 |
|---|---|---|---|
| Cost of biological assets Accumulated fair value adjustments |
18,213 (10,143) |
6,885 501 |
10,864 411 |
| Total biological assets | 8,070 | 7,386 | 11,275 |
The following represents a reconciliation of changes in the carrying amount of the Group's biological assets:
| Unaudited (USD 1,000) | 30 June 2020 | 30 June 2019 | 31 Dec 2019 |
|---|---|---|---|
| Biological assets at beginning of period | 11,275 | 3,283 | 3,283 |
| Gain or loss arising from changes in fair value less costs to sell | (11,216) | 704 | 458 |
| Increases due to production and purchases | 13,059 | 5,327 | 13,865 |
| Decreases due to harvest | (2,428) | (1,661) | (5,978) |
| Decreases due to mortality | (2,576) | (257) | (297) |
| Net exchange rate differences | (44) | (10) | (56) |
| Biological assets at end of period | 8,070 | 7,386 | 11,275 |
| Unaudited (USD 1,000) | 30 June 2020 | 30 June 2019 | 31 Dec 2019 |
|---|---|---|---|
| Live weight of biomass (in tons) | |||
| Non-harvestable fish | 354 | 96 | 354 |
| Harvestable fish | 1,666 | 1,008 | 821 |
| Total live weight of biomass (in tons) | 2,020 | 1,104 | 1,175 |
| Number of fish (in thousands) | |||
| Non-harvestable fish | 3,490 | 2,901 | 4,114 |
| Harvestable fish | 1,176 | 292 | 300 |
| Total number of fish (in thousands) | 4,666 | 3,193 | 4,414 |
| Volume of fish harvested during the year (tons gutted weight) | 353 | 288 | 1,022 |
Property, plant, and equipment consisted of the following:
| Unaudited (USD 1,000) | Land | Buildings | Production, plant, and machinery |
Equipment and other movables |
Software | Assets under construction |
Total |
|---|---|---|---|---|---|---|---|
| At 1 January 2020 | |||||||
| Cost | 8,714 | 15,218 | 22,840 | 1,019 | 180 | 167,070 | 215,041 |
| Less: accumulated depreciation | - | (1,317) | (3,746) | (362) | - | - | (5,425) |
| Net book amount | 8,714 | 13,901 | 19,094 | 657 | 180 | 167,070 | 209,616 |
| Six months ended 30 June 2020 | |||||||
| Opening net book amount | 8,714 | 13,901 | 19,094 | 657 | 180 | 167,070 | 209,616 |
| Additions | - | - | - | 34 | 105 | 32,619 | 32,758 |
| Reclassifications | - | 881 | 520 | 73 | - | (1,474) | - |
| Disposals | - | - | - | - | - | - | - |
| Depreciation charge | - | (395) | (782) | (89) | (30) | - | (1,296) |
| Reversed depreciation | - | - | - | - | - | - | - |
| Net exchange rate differences | - | 63 | 70 | 3 | (2) | (65) | 69 |
| Closing net book amount | 8,714 | 14,450 | 18,902 | 678 | 253 | 198,150 | 241,147 |
| At 30 June 2020 | |||||||
| Cost | 8,714 | 16,162 | 23,430 | 1,129 | 283 | 198,150 | 247,868 |
| Less: accumulated depreciation | - | (1,712) | (4,528) | (451) | (30) | - | (6,721) |
| Net book amount | 8,714 | 14,450 | 18,902 | 678 | 253 | 198,150 | 241,147 |
| Unaudited (USD 1,000) | Land | Buildings | Production, plant, and machinery |
Equipment and other movables |
Software | Assets under construction |
Total |
|---|---|---|---|---|---|---|---|
| At 1 January 2019 | |||||||
| Cost | 3,691 | 10,251 | 21,677 | 702 | - | 93,272 | 129,593 |
| Less: accumulated depreciation | - | (715) | (2,368) | (210) | - | - | (3,293) |
| Net book amount | 3,691 | 9,536 | 19,309 | 492 | - | 93,272 | 126,300 |
| Year ended 31 December 2019 | |||||||
| Opening net book amount | 3,691 | 9,536 | 19,309 | 492 | - | 93,272 | 126,300 |
| Additions | 5,023 | - | - | 323 | 180 | 80,631 | 86,157 |
| Reclassifications | - | 5,176 | 1,624 | 14 | - | (6,814) | - |
| Disposals | - | (30) | (83) | (16) | - | (12) | (141) |
| Depreciation charge | - | (631) | (1,475) | (161) | - | - | (2,267) |
| Reversed depreciation | - | 29 | 97 | 9 | - | - | 135 |
| Net exchange rate differences | - | (179) | (378) | (4) | - | (7) | (568) |
| Closing net book amount | 8,714 | 13,901 | 19,094 | 657 | 180 | 167,070 | 209,616 |
| At 31 December 2019 | |||||||
| Cost | 8,714 | 15,218 | 22,840 | 1,019 | 180 | 167,070 | 215,041 |
| Less: accumulated depreciation | - | (1,317) | (3,746) | (362) | - | - | (5,425) |
| Net book amount | 8,714 | 13,901 | 19,094 | 657 | 180 | 167,070 | 209,616 |
On 21 April 2020, the Group amended the 2019 DNB Credit Facility (the "2020 DNB Credit Facility") with DNB ASA which, among other conditions, increased the aggregate amount of USD 86m to USD 210m. Under the amended terms, the USA Term Loan was increased from USD 54m to USD 70m, the USA RCF was increased from USD 11m to USD 26m, and the DK RCF remained unchanged at USD 4m. The USD 17m bridge facility under the 2019 DNB Credit Facility was removed, and a delayed draw term loan of USD 110m was extended to the Group towards Phase 2 construction.
The Group's borrowings consisted of the following:
| Unaudited (USD 1,000) | 30 June 2020 | 30 June 2019 | 31 Dec 2019 |
|---|---|---|---|
| ASUS has a USD 70m term loan with DNB (the "USA Term Loan"). The USA Term Loan bears an amended interest rate of LIBOR plus 4.5% and matures on 21 October 2021. USD 70m was drawn on the USA Term Loan as of 30 June 2020. |
69,960 | 27,202 | 27,398 |
| ASUS has a three-year USD 26m revolving credit facility commitment with DNB (the "USA RCF"). The USA RCF will finance ASUS' working capital requi rements, and no funds have been drawn as of 30 June 2020. |
- | - | - |
| ASDK has a three-year USD 4m revolving credit facility commitment with DNB (the "DK RCF"). The DK RCF will finance ASDK's working capital requirements, and no funds have been drawn as of 30 June 2020. |
- | - | - |
| ASUS had a USD 17m bridge facility with DNB. During the year ended 31 December 2019, USD 12m was drawn and subsequently repaid following the completion of the Group's 8 May 2019 equity raise. |
- | - | - |
| ASUS has a two-year loan payable (the "PPP Loan") to PNC Bank, National Association ("PNC"). The PPP Loan was obtained on April 2020 under the Paycheck Protection Program (the "Program") as part of the Coronavirus Aid, Relief, and Economic Security ("CARES") Act passed in March 2020. The PPP Loan bears an interest rate of 1% and matures on April 2022. Payment is deferred for the first six months at which point an the outstanding principal of the PPP Loan that is not unforgiven under the Program is payable to the maturity date. |
1,156 | - | - |
| Total borrowings Less: short-term portion of borrowings |
71,116 - |
27,202 (67) |
27,398 (79) |
| Long-term portion of borrowings | 71,116 | 27,135 | 27,319 |
During the year ended 31 December 2019, ASUS incurred USD 3.1m in debt issuance costs in connection to the USA Term Loan under the 2019 DNB Credit Facility. Total unamortized debt issuance costs as of 31 December 2019 were USD 2.6m and were presented against its respective portion of short-term and long-term borrowings.
At 21 April 2020, total unamortized debt issuance costs presented against borrowings were USD 2.4m. Upon amending the USA Term Loan under the 2020 DNB Credit Facility, ASUS incurred USD 5.8m in new debt issuance costs. In accordance with IFRS 9 Financial Instruments, the previously unamortized debt issuance costs of USD 2.4m and USD 5.8m in new debt issuance costs were recognized as part of finance expense in the consolidated statements of operations.
The total number of shares issued and outstanding consisted of the following:
| 30 June 2020 | |||
|---|---|---|---|
| Number of shares | % of shares | ||
| Alsco AS | 9,459,849 | 13.27% | |
| Regents of the University of Michigan | 4,360,478 | 6.12% | |
| Vatne Equity AS | 4,050,000 | 5.68% | |
| Skagen Kon-Tiki Verdipapirfond | 3,877,995 | 5.44% | |
| State Street Bank and Trust Comp | 2,656,208 | 3.73% | |
| Brown Brothers Harriman & Co. | 2,275,092 | 3.19% | |
| Morgan Stanley & Co. Int. Plc. | 2,185,933 | 3.07% | |
| Citibank, N.A. | 2,063,786 | 2.90% | |
| U.S. Bank National Association | 2,030,227 | 2.85% | |
| Pershing LLC | 1,342,019 | 1.88% | |
| Joh Johannson Eiendom AS | 1,340,926 | 1.88% | |
| Verdipapirfondet Norge Selektiv | 1,234,611 | 1.73% | |
| Lani Invest AS | 1,112,997 | 1.56% | |
| JEA Invest AS | 1,072,270 | 1.50% | |
| UBS Switzerland AG | 1,032,351 | 1.45% | |
| Blue Future Holding AS | 1,021,621 | 1.43% | |
| Norron Sicav - Active | 935,861 | 1.31% | |
| Goldman Sachs & Co. LLC | 876,653 | 1.23% | |
| Verdipapirfondet DNB Norge | 842,222 | 1.18% | |
| Norron Sicav - Target | 806,200 | 1.13% | |
| Total number of shares attributed to the 20 largest shareholders | 44,577,299 | 62.54% | |
| Total number of shares attributed to other shareholders | 26,698,801 | 37.46% | |
| Total number of shares issued and outstanding | 71,276,100 | 100.00% |
On 4 May 2020, Atlantic Sapphire AS converted from a private company to Atlantic Sapphire ASA, a public company. On 5 May 2020, Atlantic Sapphire ASA listed on the Oslo Stock Exchange under the ticker symbol "ASA".
Recent developments with respect to the COVID-19-virus (the "Coronavirus"), an infectious virus closely related to the SARS virus, has impacted supply chain and construction operations of the Group. In addition, Norwegian salmon prices have experienced a downward trend, pressured down by various factors including concerns over lower global exports due to the Coronavirus. Ultimately, the consequences and timeline of the Coronavirus are still unclear and the overall effect on the business is uncertain.
On 28 July 2020, ASUS initiated an emergency harvest from one of its partially commissioned grow-out systems. As a result of the event, approximately 200,000 salmon with a total weight of approximately 400 tons (HOG) were harvested. Other grow-out systems of the Miami Bluehouse were unaffected. The exact chain of events is still under investigation and preliminary findings do not indicate intoxication or disease as the cause of the event. Rather, the Group believes disruptive construction work close to the operating environment acutely stressed the fish through loud sounds and severe vibrations. Recent challenges of delayed construction and commissioning of critical components, in part because of the Coronavirus pandemic impact, have resulted in increased operational risk and limit the tools the Group has to deal with non-conformities. The Group believes that the event would have likely been mitigated if the permanent fish movement system would have been fully commissioned. The Group is still assessing the complete financial impact of the event including insurance proceeds.
www.atlanticsapphire.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.